Kari J. Brewer Savannah

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Kari B. Savannah, Kari Brewer, Kari Brewer Savannah, Kari J Brewer Savannah, Kari J. Brewer, Kari J. Brewer Savannah, Kari Savannah

Publications

457

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Baylor College of Medicine Brigham and Women's Hospital Harvard University

About

Kari J. Brewer Savannah is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, surgical oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	203
2	Cell Biology	2	2	127
3	Pathology	2	2	122
4	Pharmacology	2	2	127
5	Obstetrics	1	1	76

Kari J. Brewer Savannah

Publications

449

Citations

H-Index

Page 1

	Year	Citations
An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors Tingsheng Peng, Pingyu Zhang, Jeffery Liu, Laboratory Investigation Drug TargetingMedicineReceptor Tyrosine KinasePharmacologyCell Biology	2010	81
Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s Experience Kristelle Lusby, Kari J. Brewer Savannah, Elizabeth G. Demicco, Annals of Surgical Oncology Surgical OncologyUterine FibroidsSingle Institution ’Tumoral PathologyMedicine	2013	76
A Small-Molecule Inhibitor Targeting the Mitotic Spindle Checkpoint Impairs the Growth of Uterine Leiomyosarcoma Weiwei Shan, Patricia Y. Akinfenwa, Kari J. Brewer Savannah, Clinical Cancer Research	2012	57
Peptide-Based Imaging Agents Targeting Phosphatidylserine for the Detection of Apoptosis Chiyi Xiong, Kari J. Brewer Savannah, Shaoli Song, Journal of Medicinal Chemistry	2011	53
Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma Kari J. Brewer Savannah, Elizabeth G. Demicco, Kristelle Lusby, Clinical Cancer Research	2012	48
Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors Markus P. Ghadimi, Gonzalo Lopez, Keila E. Torres, Molecular Cancer Therapeutics Surgical OncologyTumor InnervationPi3k/mtor AxisPathologyMpnst Growth	2012	46
Acidic/IQ Motif Regulator of Calmodulin John A. Putkey, M. Neal Waxham, Tara Gaertner, Journal of Biological Chemistry	2007	45
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value Elizabeth G. Demicco, Genevieve M. Boland, Kari J. Brewer Savannah, Histopathology	2014	43

Page 1